149 related articles for article (PubMed ID: 12712483)
41. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
[TBL] [Abstract][Full Text] [Related]
42. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
[TBL] [Abstract][Full Text] [Related]
43. Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study.
Strom SS; Spitz MR; Yamamura Y; Babaian RJ; Scardino PT; Wei Q
Prostate; 2001 Jun; 47(4):269-75. PubMed ID: 11398174
[TBL] [Abstract][Full Text] [Related]
44. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia.
Seedhouse CH; Das-Gupta EP; Russell NH
Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664
[TBL] [Abstract][Full Text] [Related]
45. Global DNA methylation in relation to hMLH1 and hMSH2 protein immunoreactivity in sporadic human endometrial carcinomas.
Miturski R; Postawski K; Semczuk A; Bogusiewicz M; Baranowski W; Jakowicki JA; Keith G
Int J Mol Med; 2003 May; 11(5):569-74. PubMed ID: 12684691
[TBL] [Abstract][Full Text] [Related]
46. Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features.
Tomaszewska R; Okoń K; Stachura J
Pol J Pathol; 2003; 54(1):31-7. PubMed ID: 12817878
[TBL] [Abstract][Full Text] [Related]
47. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
48. Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder.
Saetta AA; Goudopoulou A; Korkolopoulou P; Voutsinas G; Thomas-Tsagli E; Michalopoulos NV; Patsouris E
Eur J Surg Oncol; 2004 Sep; 30(7):796-803. PubMed ID: 15296997
[TBL] [Abstract][Full Text] [Related]
49. Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours.
Ghimenti C; Tannergård P; Wahlberg S; Liu T; Giulianotti PG; Mosca F; Fornaciari G; Bevilacqua G; Lindblom A; Caligo MA
Br J Cancer; 1999 Apr; 80(1-2):11-6. PubMed ID: 10389971
[TBL] [Abstract][Full Text] [Related]
50. Characterization of mutator pathway in younger-age-onset colorectal adenocarcinomas.
Roh SA; Kim HC; Kim JS; Kim JC
J Korean Med Sci; 2003 Jun; 18(3):387-91. PubMed ID: 12808326
[TBL] [Abstract][Full Text] [Related]
51. Detection of an involvement of the human mismatch repair genes hMLH1 and hMSH2 in nucleotide excision repair is dependent on UVC fluence to cells.
Lee DF; Drouin R; Pitsikas P; Rainbow AJ
Cancer Res; 2004 Jun; 64(11):3865-70. PubMed ID: 15172995
[TBL] [Abstract][Full Text] [Related]
52. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers.
Takahashi Y; Kondo K; Hirose T; Nakagawa H; Tsuyuguchi M; Hashimoto M; Sano T; Ochiai A; Monden Y
Mol Carcinog; 2005 Mar; 42(3):150-8. PubMed ID: 15605365
[TBL] [Abstract][Full Text] [Related]
53. [Clinical analysis and molecular genetic study of hereditary nonpolyposis colorectal cancer kindreds].
Luo DC; Cai Q; Sun MH; Ni YZ; Tao CW; Chen ZJ; Shi DR
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):158-62. PubMed ID: 15062061
[TBL] [Abstract][Full Text] [Related]
54. Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas.
Chapusot C; Martin L; Mungra N; Rageot D; Bouvier AM; Bonithon Kopp C; Ponnelle T; Faivre J; Piard F
Histopathology; 2003 Jul; 43(1):40-7. PubMed ID: 12823711
[TBL] [Abstract][Full Text] [Related]
55. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
56. Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide.
Marra G; D'Atri S; Corti C; Bonmassar L; Cattaruzza MS; Schweizer P; Heinimann K; Bartosova Z; Nyström-Lahti M; Jiricny J
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7164-9. PubMed ID: 11416201
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical detection of hMLH1 and hMSH2 proteins in vulvar carcinoma.
Kwasniewska A; Postawski K; Gozdzicka-Józefiak A; Zdunek M; Korobowicz E; Miturski R
Int J Mol Med; 2005 Jun; 15(6):955-61. PubMed ID: 15870899
[TBL] [Abstract][Full Text] [Related]
58. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Morimoto H; Tsukada J; Kominato Y; Tanaka Y
Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
[TBL] [Abstract][Full Text] [Related]
59. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.
Wang YC; Lu YP; Tseng RC; Lin RK; Chang JW; Chen JT; Shih CM; Chen CY
J Clin Invest; 2003 Mar; 111(6):887-95. PubMed ID: 12639995
[TBL] [Abstract][Full Text] [Related]
60. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
